The purpose of this study is to determine the immunogenicity and tolerability of the DTaP-IPV-HBV/Hib combination vaccine Infanrix hexa and the heptavalent pneumococcal conjugate vaccine Prevenar in pediatric recipients of allogeneic haematopoietic stem cell transplantation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
53
University Childrens Hospital
Berlin, Germany
University Children Hospital
Düsseldorf, Germany
University Children Hospital
Erlangen, Germany
serologic response at 1 months following primary three dose vaccination series
Time frame: first month
serologic response at 1 months following booster immunization
Time frame: first month
tolerability of primary and booster vaccination
Time frame: at least monthly
identification of factors influencing immunogenicity and tolerability of study vaccines
Time frame: at least monthly
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University Children Hospital
Frankfurt, Germany
University Childrens Hospital
Freiburg im Breisgau, Germany
University Childrens Hospital
Giessen, Germany
University Childrens Hospital
Hamburg, Germany
University Childrens Hospital
Hanover, Germany
University Childrens Hospital
Jena, Germany
University Childrens Hospital
Münster, Germany
...and 1 more locations